ABSI vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 05, 2026

ABSI

39.2
AI Score
VS
CURI Wins

CURI

41.5
AI Score

Investment Advisor Scores

ABSI

39score
Recommendation
SELL

CURI

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABSI CURI Winner
Forward P/E 0 9.0334 Tie
PEG Ratio 0 0 Tie
Revenue Growth -46.4% 22.3% CURI
Earnings Growth 0.0% 1400.0% CURI
Tradestie Score 39.2/100 41.5/100 CURI
Profit Margin 0.0% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CURI

Relative Price Performance (Last 90 Days)

ABSI 1M: +6.3% · 3M: +37.8% CURI 1M: +1.1% · 3M: -2.3%

Current Technical Phase

ABSI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.5 · Price: $8.82

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $2.71

Fundamentals Snapshot

Metric ABSI CURI
Market Cap
Forward P/E -13.1 8.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.5% 0.2%
Gross Margin -54.0% 0.6%
Operating Margin -107.4% 0.4%
EPS -0.79 -0.01
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.